Macfos Ltd
543787Macfos Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.
The sharpest disagreement: profits are rising, but only −53% of the last 3 years' profit arrived as operating cash — the gap between the P&L and the bank account is the thing to watch.
The price is in a confirmed uptrend (31 weeks in) while the P/E sits at the 55th percentile of its own 2-year range. Underneath, the last four quarters read improving — profit +102.7% year on year, and −53% of the last 3 years' profit arrived as cash. What settles it: whether the cash starts following the profit.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Macfos Ltd trades at ₹1,098, in a confirmed uptrend and 31 weeks into that stage. That is +17.1% against its own 200-day average. It sits at 68% of a 52-week range of ₹659 to ₹1,300. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (4 weeks and counting).
Today the stock is in a confirmed uptrend — week 31 of stage 2, confirmed. At ₹1,098 it trades +17.1% versus its 200-day average and sits at 68% of its 52-week range (₹659–₹1,300).
Against the market, two honest reads. Cumulative: over the last 3.4 years the stock moved +666% while the NIFTY 500 moved +57% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (4 weeks and counting; last ahead the week of 2026-07-03) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Macfos Ltd trades at 44.4× P/E, mid-range by its own standards (55th percentile). Its long-run median P/E is 43.1×, measured across 2.2 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 44.4× is mid-range by its own standards (55th percentile), against a long-run median of 43.1× measured over 2.2 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year annual EPS moved +43.6% against a +53.2% price move — the price outran earnings, pushing the multiple UP its own range.
Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Macfos Ltd reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 7 quarters across 0 curves, on partial evidence.
Why it matters: with too little history, an honest page says so instead of guessing a trajectory.
One or more growth curves carry a base-effect spike — a large year-on-year move off a near-zero or loss-making comparable quarter. Those spikes are capped before the classifier reads the trajectory, and shown pinned on the chart, so a single distorted quarter does not drive the stage call.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +21.2% | — | — | — |
| Profit | +44.4% | — | — | — |
| EPS | +43.6% | — | — | — |
| Share price | +53.2% | +57.5% | — | — |
4-Factor Sector Score
60.5/100 — rank 4 of 13 in E-Commerce - Platform - Utility · 71% evidence confidence
Macfos Ltd scores 60.5 out of 100 against the 13 companies it is compared with in E-Commerce - Platform - Utility, ranking 4. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 19.1 + 18.9 + 9.7 + 12.8 = 60.5. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Macfos Ltd reported ₹102 Cr of revenue in the Mar 26 quarter, +63.2% year on year. That is the 2nd straight quarter of year-on-year growth. Over 2 years it has compounded at 57.2% a year. The last full year, FY26, came in at ₹309 Cr. The last four reported quarters add to ₹309 Cr.
FY26 revenue came in at ₹309 Cr (+21.2% on the year), capping 2 years at 57.2% compound. The latest quarter (Mar 26) printed ₹102 Cr, +63.2% year on year — the 2nd consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +29.0% growth against the decade's 57.2% — the current year is running slower than its own long-run rate.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Macfos Ltd's operating margin is 13.6% in the Mar 26 quarter, +3.3 percentage points against the same quarter a year ago. Across 3 fiscal years the operating margin has ranged 10.0% to 12.0%. The current quarter is running above every full year in that window.
The latest quarter's operating margin is 13.6%, +3.3 pp against the same quarter a year ago. Across 3 fiscal years the operating margin has ranged 10.0%–12.0%.
Why the margin moved: operating margin went +3.3 pp year on year while gross margin went +2.3 pp — the gain came mostly from the gross line: input costs and pricing.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Macfos Ltd earned ₹9.9 Cr of net profit in the Mar 26 quarter, +102.7% year on year. It is the 2nd consecutive quarter of growth. Full-year FY26 profit was ₹26.0 Cr. The 2-year compound rate is 53.7%. That is 9.7% of the quarter's revenue. The same quarter a year earlier earned ₹4.9 Cr.
Mar 26 profit was ₹9.9 Cr, +102.7% year on year — the 2nd consecutive quarter of growth. On the full year, FY26 printed ₹26.0 Cr (+44.4%), and the 2-year compound rate is 53.7%.
Why profit moved: revenue contributed +63.2% and the margin +3.3 pp — the quarter was margin-led: most of the profit growth came from keeping more of each sale.
Pace comparison, last four quarters: profit +53.3% vs revenue +29.0%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra rupee of revenue drops more to the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years −53% of Macfos Ltd's reported profit arrived as operating cash — a gap worth watching. In FY26 that was ₹−8.0 Cr of operating cash against ₹26.0 Cr of profit. After ₹4.0 Cr of capital spending, ₹−12.0 Cr was left as free cash. Cash resolution here is annual, because quarterly cash statements are not published.
FY26: operating cash of ₹−8.0 Cr against reported profit of ₹26.0 Cr, leaving free cash of ₹−12.0 Cr after ₹4.0 Cr of capital spending. Across the last 3 fiscal years the conversion rate is −53% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
🚨 Why conversion sits at −53%: the cash cycle stretched 38 days between FY24 and FY26 — more of each rupee of profit waits inside the cycle before arriving. Less than 70% of profit arriving as cash is the thing to watch on this page.
Router verdict: conversion is below par and the cash cycle has stretched 38 days — the next section's job is to find where the cash is stuck.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Macfos Ltd's cash conversion cycle runs 113 days in FY26, up from 75 days in FY24. Capital spending ran ₹9.0 Cr over the last 2 years. At FY26 sales of ₹309 Cr each day of that cycle holds about ₹0.8 Cr, so roughly ₹96.0 Cr sits inside the business at any moment.
FY26: debtors at 16 days, inventory at 122 days — roughly 4.0 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 113 days, looser than FY24's 75.
The full loop: cash goes out to suppliers and production on day 0; stock waits 122 days to sell; customers pay about 16 days after that; and suppliers themselves are paid at 26 days — netting out to the 113-day cycle.
In money terms: at FY26 sales of ₹309 Cr, each day of the cycle holds about ₹0.8 Cr — so the 113-day loop keeps roughly ₹96.0 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹9.0 Cr over the last 2 fiscal years against ₹3.0 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹0.0 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: the working-capital loop is the cash sink the router flagged — watch the cycle, not the P&L.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.
Macfos Ltd earns a ROCE of 34% in FY26. A return-on-invested-capital spread against the cost of capital is not computable from what is held here. The wiring behind it is 8.4% net margin on 1.93× asset turns.
FY26 ROCE is 34%.
Why the return is what it is — the wiring (FY26): 8.4% net margin × 1.93× asset turns × 1.67× balance-sheet leverage ≈ 27.1% on equity. Margin does its share; leverage is a meaningful part of the equation.
Debt Debt-to-equity says how much of the business is funded by borrowings; interest cover says how many times operating profit pays the interest bill. Low and high, respectively, is the safe corner.
Macfos Ltd carries ₹36.0 Cr of borrowings against ₹96.0 Cr of equity in FY26, a debt-to-equity of 0.38. Operating profit covers the interest bill 12×. Over 2 years borrowings went from ₹8.0 Cr to ₹36.0 Cr. Capital spending ran ₹9.0 Cr across the last 2 of those years.
FY26: borrowings of ₹36.0 Cr against equity of ₹96.0 Cr — a debt-to-equity of 0.38. Operating profit covers the interest bill 12×. Over 2 years borrowings went from ₹8.0 Cr to ₹36.0 Cr while capital spending ran ₹9.0 Cr in just the last 2 — part of the build-out is riding on borrowed money.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
No holder of Macfos Ltd moved a full percentage point over the last two years — the register is quiet. Foreign institutions moved −0.1 points over the same window, to 0.2%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Domestic institutions: +0.8 points over 8 quarters to 6.1%; Foreign institutions: −0.1 points over 8 quarters to 0.2%; Promoters: +0.0 points over 8 quarters to 69.1%.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Macfos Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Creative Newtech LtdCNL | 70.0/100Favorable setup83% evidence | BREAKING OUT | 24.5/35 Revenue 52.3% · PAT 32.1% · OPM change 0.3 pp 83% evidence | 13.2/25 ROCE 18.8% · OPM 4% 95% evidence | 12.3/20 P/E 21.2× · PEG — 50% evidence | 20.0/20 RS sector 39.7% · RS bench 43.2% · 1Y 51.1%7 of 12 weeks ahead 100% evidence |
| Exact sum: 24.5 + 13.2 + 12.3 + 20 = 70 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2MPS LtdMPSLTD | 63.5/100Mixed-positive evidence94% evidence | TURNING | 19.0/35 Revenue 10% · PAT 19% · OPM change 7 pp 100% evidence | 22.0/25 ROCE 39.3% · OPM 34% 100% evidence | 13.6/20 P/E 25.2× · PEG 0.43 100% evidence | 8.9/20 RS sector -13.2% · RS bench 36.1% · 1Y 12.1%10 of 10 weeks ahead 70% evidence |
| Exact sum: 19 + 22 + 13.6 + 8.9 = 63.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3Indiamart Intermesh LtdINDIAMART | 63.2/100Mixed-positive evidence94% evidence | ASLEEP | 15.3/35 Revenue 12.7% · PAT -16.6% · OPM change 0 pp 100% evidence | 19.8/25 ROCE 28% · OPM 32% 100% evidence | 18.2/20 P/E 21.9× · PEG 0.68 100% evidence | 9.9/20 RS sector 3.9% · RS bench -19.7% · 1Y -29.7%0 of 10 weeks ahead 70% evidence |
| Exact sum: 15.3 + 19.8 + 18.2 + 9.9 = 63.2 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 4Macfos Ltdthis page543787 | 60.5/100Mixed-positive evidence71% evidence | LEADER | 19.1/35 Revenue 21.1% · PAT 43.1% · OPM change 3.3 pp 83% evidence | 18.9/25 ROCE 33.8% · OPM 13.6% 76% evidence | 9.7/20 P/E 44.4× · PEG — 15% evidence | 12.8/20 RS sector 23.3% · RS bench 28.1% · 1Y 47.2%12 of 12 weeks ahead 100% evidence |
| Exact sum: 19.1 + 18.9 + 9.7 + 12.8 = 60.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5RNFI Services LtdRNFI | 58.3/100Thin evidence · provisional57% evidence | ASLEEP | 21.7/35 Revenue — · PAT — · OPM change 2.4 pp 45% evidence | 16.4/25 ROCE 27.3% · OPM 6.7% 95% evidence | 10.6/20 P/E 24.6× · PEG — 15% evidence | 9.6/20 RS sector 2.6% · RS bench -8% · 1Y 12.2%0 of 10 weeks ahead 70% evidence |
| Exact sum: 21.7 + 16.4 + 10.6 + 9.6 = 58.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 6MSTC LtdMSTCLTD | 56.7/100Mixed-positive evidence72% evidence | TURNING | 17.3/35 Revenue 18.6% · PAT -46.4% · OPM change 5 pp 83% evidence | 20.1/25 ROCE 30.3% · OPM 64% 76% evidence | 9.9/20 P/E 19.9× · PEG — 50% evidence | 9.4/20 RS sector -5.3% · RS bench 22.1% · 1Y 23.3%7 of 10 weeks ahead 70% evidence |
| Exact sum: 17.3 + 20.1 + 9.9 + 9.4 = 56.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 7Pine Labs LtdPINELABS | 53.5/100Mixed-positive evidence63% evidence | ASLEEP | 28.2/35 Revenue 19.5% · PAT 100% · OPM change 6 pp 100% evidence | 6.8/25 ROCE 4.2% · OPM 13% 100% evidence | 8.5/20 P/E 124× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y —0 of 10 weeks ahead 0% evidence |
| Exact sum: 28.2 + 6.8 + 8.5 + 10 = 53.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8One 97 Communications LtdPAYTM | 52.8/100Mixed-positive evidence87% evidence | TURNING | 25.2/35 Revenue 22.6% · PAT 100% · OPM change 4.2 pp 100% evidence | 4.8/25 ROCE 5% · OPM 8% 100% evidence | 8.3/20 P/E 106× · PEG 1.85 65% evidence | 14.5/20 RS sector 12.8% · RS bench 10.7% · 1Y 25.8%3 of 10 weeks ahead 70% evidence |
| Exact sum: 25.2 + 4.8 + 8.3 + 14.5 = 52.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 9Info Edge (India) LtdNAUKRI | 50.4/100Mixed-positive evidence65% evidence | TURNING | 22.4/35 Revenue 15.2% · PAT 34.7% · OPM change 7 pp 83% evidence | 11.7/25 ROCE 5.4% · OPM 38% 76% evidence | 9.4/20 P/E 55.9× · PEG — 15% evidence | 6.9/20 RS sector -7.2% · RS bench 1.7% · 1Y -14.6%4 of 11 weeks ahead 70% evidence |
| Exact sum: 22.4 + 11.7 + 9.4 + 6.9 = 50.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 10TBO Tek LtdTBOTEK | 45.0/100Mixed-negative evidence87% evidence | TURNING | 16.2/35 Revenue 69% · PAT 14.2% · OPM change 1 pp 100% evidence | 13.6/25 ROCE 18% · OPM 15% 100% evidence | 5.1/20 P/E 61.8× · PEG 6.18 65% evidence | 10.1/20 RS sector -2.5% · RS bench 5.7% · 1Y 11.7%6 of 10 weeks ahead 70% evidence |
| Exact sum: 16.2 + 13.6 + 5.1 + 10.1 = 45 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 11Just Dial LtdJUSTDIAL | 39.5/100Mixed-negative evidence87% evidence | TURNING | 19.3/35 Revenue 23.4% · PAT 100% · OPM change -1.6 pp 100% evidence | 9.1/25 ROCE 4.8% · OPM 23.5% 100% evidence | 5.0/20 P/E 43.7× · PEG 7.47 65% evidence | 6.1/20 RS sector -20.6% · RS bench 5.7% · 1Y -15.8%3 of 10 weeks ahead 70% evidence |
| Exact sum: 19.3 + 9.1 + 5 + 6.1 = 39.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 12One Mobikwik Systems LtdMOBIKWIK | 31.5/100Thin evidence · provisional59% evidence | ASLEEP | 15.6/35 Revenue -4.3% · PAT 48.9% · OPM change 24.6 pp 62% evidence | 2.0/25 ROCE -2.2% · OPM 3.5% 95% evidence | 10.0/20 P/E — · PEG — 0% evidence | 3.9/20 RS sector -13.8% · RS bench -9.2% · 1Y -20%1 of 10 weeks ahead 70% evidence |
| Exact sum: 15.6 + 2 + 10 + 3.9 = 31.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 13Urban Company LtdURBANCO | 27.5/100Adverse evidence60% evidence | ASLEEP | 7.2/35 Revenue 39.6% · PAT -80% · OPM change -14.4 pp 100% evidence | 0.3/25 ROCE -7.8% · OPM -18% 100% evidence | 10.0/20 P/E — · PEG — 0% evidence | 10.0/20 RS sector — · RS bench — · 1Y —3 of 10 weeks ahead 0% evidence |
| Exact sum: 7.2 + 0.3 + 10 + 10 = 27.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Macfos Ltd's share price today?
Macfos Ltd trades at ₹1,098, +53.2% over the past year. The company is valued at ₹1,138 Cr. The stock sits at 68% of its 52-week range of ₹659–₹1,300, +17.1% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 31 weeks in. — as of 31 July 2026.
What were Macfos Ltd's latest quarterly results?
Macfos Ltd reported revenue of ₹102 Cr and net profit of ₹9.9 Cr for the Mar 26 quarter. Revenue rose 63.2% and profit rose 102.7% year on year. Earnings per share were ₹9.53. The operating margin was 13.6%, 3.3 pp higher than a year earlier. — as of 31 July 2026.
What is Macfos Ltd's revenue?
Macfos Ltd reported revenue of ₹102 Cr in the Mar 26 quarter, +63.2% year on year. For the full FY26 fiscal year, revenue was ₹309 Cr (+21.2%). Over the last 2 years revenue compounded at 57.2% a year. — as of 31 July 2026.
What is Macfos Ltd's profit?
Macfos Ltd earned ₹9.9 Cr of net profit in the Mar 26 quarter, +102.7% year on year — the 2nd straight quarter of growth. Full-year FY26 profit was ₹26.0 Cr. The operating margin ran 13.6% in the latest quarter. — as of 31 July 2026.
What is Macfos Ltd's market cap?
Macfos Ltd's market capitalisation is ₹1,138 Cr at a share price of ₹1,098. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 31 July 2026.
What is Macfos Ltd's P/E ratio?
Macfos Ltd trades at a P/E of 44.4×, at the 55th percentile of its own 2-year range, against a long-run median of 43.1×. This is a comparison with the stock's own history, not a value call — as of 31 July 2026.
Does Macfos Ltd pay a dividend?
No — Macfos Ltd has recorded a dividend payout of 0% of profit in each of its last 3 reported fiscal years, so there is no payout history to quote. That is a reading of the filed annual statements, not an estimate. — as of 31 July 2026.
Is Macfos Ltd overvalued?
On its own history, Macfos Ltd looks mid-range against its own history: its P/E of 44.4× sits at the 55th percentile of its 2-year range (long-run median 43.1×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 31 July 2026.
Is Macfos Ltd growing?
Yes — Macfos Ltd is growing: latest-quarter revenue +63.2% year on year, profit +102.7%, and the margin +3.3 pp at 13.6%. The 2-year compound rates are 57.2% (revenue) and 53.7% (profit). The earnings engine currently reads: improving — as of 31 July 2026.
How is Macfos Ltd performing?
Macfos Ltd is in a confirmed uptrend, 31 weeks in. Its latest quarter's revenue rose 63.2% and profit rose 102.7% year on year. Against the NIFTY 500 it has been behind on a trailing-13-week view for 4 weeks. This describes what the data did, not a rating. — as of 31 July 2026.
Is Macfos Ltd in an uptrend?
Yes — the price is in a confirmed uptrend (week 31 of stage 2), trading +17.1% versus its 200-day average and at 68% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 31 July 2026.
Is Macfos Ltd beating the market?
Not lately — on a trailing-13-week view Macfos Ltd is currently behind the NIFTY 500 (4 weeks and counting; last ahead the week of 2026-07-03), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 3.4 years the stock moved +666% against the NIFTY 500's +57% — ahead of the index over the full window. — as of 31 July 2026.
Will Macfos Ltd's share price go up?
This page publishes no price forecast for Macfos Ltd. What it measures instead: the share price is ₹1,098, the price is in a confirmed uptrend 31 weeks in. Its P/E of 44.4× sits at the 55th percentile of its own 2-year range. — as of 31 July 2026.
Who owns Macfos Ltd?
Promoters hold 69.1% of Macfos Ltd, foreign institutions 0.2%, domestic institutions 6.1% and the public 24.6% (latest quarter). No holder moved a full point over the last two years — the register is quiet. — as of 31 July 2026.
Does Macfos Ltd have too much debt?
It is moderate — Macfos Ltd's debt-to-equity is 0.38, and operating profit covers the interest bill 12×. FY26 borrowings were ₹36.0 Cr against equity of ₹96.0 Cr. Read the returns on this page with that leverage in mind — as of 31 July 2026.
What is Macfos Ltd's capex?
Macfos Ltd spent ₹9.0 Cr on capital expenditure over the last 2 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹4.0 Cr, with ₹0.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 31 July 2026.
What is Macfos Ltd's cash flow?
Macfos Ltd generated ₹−8.0 Cr of operating cash flow in FY26 and ₹−12.0 Cr of free cash flow after ₹4.0 Cr of capital spending. Reported profit that year was ₹26.0 Cr, so operating cash ran behind profit. Cash-flow resolution for India is annual. — as of 31 July 2026.
Is Macfos Ltd's profit real cash?
Not fully — over the last 3 fiscal years, −53% of Macfos Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹−8.0 Cr against reported profit of ₹26.0 Cr. The cash then goes mostly into the working-capital cycle. Cash-flow resolution is annual — as of 31 July 2026.
Where is Macfos Ltd in its business cycle?
Macfos Ltd's FY26 operating margin was 12.0%, against a 3-year band of 10.0%–12.0%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 13.6%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 31 July 2026.
What could break the Macfos Ltd story?
The sharpest disagreement: profits are rising, but only −53% of the last 3 years' profit arrived as operating cash — the gap between the P&L and the bank account is the thing to watch. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 31 July 2026.
Is Macfos Ltd a stock worth studying right now?
This is not investment advice. The machine read: Macfos Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: whether the cash starts following the profit. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 31 July 2026.